The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment

Sheba Medical Center

Status: Unknown

Conditions: Efficacy; Complications

Treatments: Procedure: cataract surgery with phacoemulsification

Study type: Interventional

Funder types: Other

Identifiers

NCT00564356

SHEBA-07-3017-OS-CTIL

Details and patient eligibility

About

To assess the risks of intra- and postoperative bleeding tendency associated with cataract surgery by phacoemulsification in patients on coumadin and antiaggregant treatments.

Design: Consecutive prospective study.

Full description

To assess the risks of intra- and postoperative bleeding tendency associated with cataract surgery by phacoemulsification technique in patients on coumadin and antiaggregant treatment Design: Consecutive prospective study.

Enrollment: 75 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients who give informed consent to participate in the study

Exclusion criteria

• single eye complicated cataract

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

75 participants in 1 patient group

A

Other group

Description:

patients under coumadin and antiaggregants operated by phacoemulsification

Treatment:

Procedure: cataract surgery with phacoemulsification